Navigation Links
Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio
Date:2/4/2008

Bayview Increases High-Field MR Imaging Services to Unprecedented Number of

Claustrophobic, Elderly and Bariatric Patients

MALVERN, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Johns Hopkins Bayview Medical Center in Baltimore has become the first facility in the United States to install the newest magnetic resonance imaging (MRI) system from Siemens Medical Solutions (http://www.usa.siemens.com/healthcare) -- the MAGNETOM(R) Verio. Combining 3 Tesla (T) strength and sensitivity with a 70-cm open bore and Tim(TM) (Tot al imaging mat rix) technology, the MAGNETOM Verio is helping Hopkins Bayview to provide high-field imaging to many patients who previously could not benefit from the technology.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Certain patients, such as children or adults experiencing excessive pain or limited mobility, and the elderly, have had difficulty tolerating MRI exams. However, the Verio's short length -- the shortest 3T on the market today -- along with its large bore -- the widest 3T available -- can help reduce a patient's anxiety and discomfort. Furthermore, due to the system's wide bore and a 550-pound table-weight capacity, the MAGNETOM Verio enables clinicians to image and diagnose many obese patients, an increasingly important factor as one-in-three Americans is considered obese.

"The Verio is an exciting addition to our facility because it enables us to provide high-field imaging to new patient populations, including our bariatric patients," said Dr. Mark E. Bohlman, chairman of imaging at Johns Hopkins Bayview Medical Center. "Furthermore, the Verio is already being used to assist our clinicians in new ways, such as scanning for viable cartilage for transplant and helping create neurosurgical, pre-op planning maps."

With the strongest magnet field strength used clinically, the Verio can be used for many applications, including neurology and functional neuro evaluation, orthopedic and cartilage assessment, breast, vascular, and cardiac imaging.

"MRI is increasingly becoming the exam of choice in the U.S., with a 10 percent increase in MRI exams in just the past five years," said Jeffrey Bundy, vice president, Magnetic Resonance, Siemens Medical Solutions USA, Inc. "Siemens' Verio is allowing healthcare providers to meet this escalating demand while, at the same time, making the experience much more comfortable for the patient."

About the MAGNETOM Verio

The Verio, with the power of Tim, has up to 102 seamlessly integrated matrix coil elements and up to 32 independent radiofrequency channels, enabling advanced clinical applications. Tim allows flexible combinations of up to four different coils that make patient and coil repositioning virtually unnecessary.
Standard on the Verio are advanced syngo applications:

-- BLADE, correcting for motion artifacts encountered in neuro, ortho, and

abdominal procedures

-- TWIST, enabling 3D MR angiography for arterial and venous phases

-- SPACE, generating 3D acquisitions for complex head, spine, abdomen,

pelvic, and ortho exams

-- GRAPPA, identifying small renal cysts with shorter breath-holds and

increased throughput

About Johns Hopkins Bayview

Johns Hopkins Bayview is a full-service, JCAHO-accredited academic medical center. Founded in 1773, it is one of the oldest, continuous health care systems on the East Coast. Part of the Johns Hopkins Health System, Johns Hopkins Bayview has more than 700 beds and is home to one of Maryland's most comprehensive neonatal intensive care units, a sleep disorders center, an area-wide trauma center, the state's only regional burn center and a wide variety of nationally recognized post-acute care and geriatrics programs.

About Siemens Healthcare

Siemens Healthcare is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of euro 9.85 billion, orders of euro 10.27 billion, and group profit of euro 1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare


'/>"/>
SOURCE Siemens Medical Solutions
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Johnson & Johnson Announces Changes to Accelerate Growth
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
5. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
6. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
7. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
8. RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
9. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
10. Access Pharmaceuticals Announces $2.7 Million New Equity
11. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing a ... array of biochemical analyses critical for Lead Discovery. The company’s Lead Discovery ... programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence times ...
(Date:2/23/2017)... , Feb. 23, 2017  Seattle,s upscale Capitol Hill ... a strange place for a head lice treatment salon to ... between a Tuscan restaurant and a French bistro on E ... perfect. "We aren,t just any old lice clinic, we pride ... feel comfortable, and release some of the stigma associated with ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... the 12th annual Inventors Recognition Reception at Purdue Research Park of ... faculty member in recognition of outstanding contributions to, and success with, commercializing discoveries ...
Breaking Biology Technology:
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):